Merozoite surface protein 1 (MSP-1) Ahlborg, N., I. T. Ling et al. (2000). "Linkage of exogenous T- cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP119 can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP119." Infect. Immunity 68(4): 2102-2109. al-Yaman, F., B. Genton et al. (1996). "Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity." Am J Trop Med Hyg 54(5): 443-8. al-Yaman, F., B. Genton et al. (1997). "Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study." Trans R Soc Trop Med Hyg 91(5): 602-5. Alonso, P. L., M. C. Lopez et al. (1998). "Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children." Parasite Immunol 20(2): 63-71. Anders, R. F. and J. A. Smythe (1989). "Polymorphic antigens in Plasmodium falciparum." Blood 74(6): 1865-75. Andersen, E., T. R. Jones et al. (1997). "Assessment of age- dependent immunity to malaria in transmigrants." Am J Trop Med Hyg 56(6): 647-9. Ardeshir, F., J. E. Flint et al. (1985). "Expression of Plasmodium falciparum surface antigens in Escherichia coli." Proc Natl Acad Sci USA 82: 2518-2522. Aucan, C., Y. Traoré et al. (2000). "High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria." Infect. Immunity 68(3): 1252-1258. Babiker, H., L. Ranford-Cartwright et al. (1994). "Genetic evidence that RI chloroquine resistance of Plasmodium falciparum is caused by recrudescence of resistant parasites." Transactions of the Royal Society of Tropical Medicine & Hygiene 88(3): 328-31. Babiker, H. A., L. C. Ranford-Cartwright et al. (1994). "Random mating in a natural population of the malaria parasite Plasmodium falciparum." Parasitology 109(Pt 4): 413-21. Babiker, H. A., J. Lines et al. (1997). "Population structure of Plasmodium falciparum in villages with different malaria endemicity in east Africa." Am J Trop Med Hyg 56(2): 141-7. Babiker, H. A. (1998). "Unstable malaria in Sudan: the influence of the dry season. Plasmodium falciparum population in the unstable malaria area of eastern Sudan is stable and genetically complex." Trans R Soc Trop Med Hyg 92(6): 585-9. Babiker, H. A., A. M. Abdel-Muhsin et al. (1998). "Characteristics of Plasmodium falciparum parasites that survive the lengthy dry season in eastern Sudan where malaria transmission is markedly seasonal." Am J Trop Med Hyg 59(4): 582-90. Babiker, H. A. (1998). "Unstable malaria in the Sudan: the influence of the dry season - Plasmodium falciparum population in the unstable malaria area of eastern Sudan is stable and genetically complex." Trans. Roy. Soc. Trop. Med. Hyg. 92(6): 585- 589. Banyal, H. S. and J. Inselburg (1985). "Isolation and characterization of parasite-inhibitory Plasmodium falciparum monoclonal antibodies." Am J Trop Med Hyg 34: 1055-1064. Barnwell, J. W. and M. R. Galinski (1991). "The adhesion of malaria merozoite proteins to erythrocytes: a reflection of function?" Res. Immunol. 142(8): 666-672. Bates, M. D., C. I. Newbold et al. (1988). "Protective immunity to malaria: studies with cloned lines of Plasmodium chabaudi chabaudi in CBA/Ca mice. III. Protective and suppressive responses induced by immunization with purified antigens." Parasite Immunol 10(1): 1-15. Benjamin, P. A., I. T. Ling et al. (1999). "Antigenic and sequence diversity at the C-terminus of the merozoite surface protein-1 from rodent malaria isolates, and the binding of protective monoclonal antibodies." Mol. Biochem. Parasitol. 104(2): 147-156. Binks, R. H. and D. J. Conway (1999). "The major allelic dimorphisms in four Plasmodium falciparum merozoite proteins are not associated with alternative pathways of erythrocyte invasion." Mol. Biochem. Parasitol. 103(1): 123-127. Blackman, M. J., H. G. Heidrich et al. (1990). "A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies." J Exp Med 172(1): 379-382. Blackman, M. J., H. Whittle et al. (1991). "Processing of the Plasmodium falciparum major merozoite surface protein-1: is shed prior to erythrocyte invasion." Mol Biochem Parasitol 49(1): 35- 44. Blackman, M. J., I. T. Ling et al. (1991). "Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor- like domains." Mol Biochem Parasitol 49(1): 29-34. Blackman, M. J. and A. A. Holder (1992). "Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1." Mol Biochem Parasitol 50(2): 307-15. Blackman, M. J. and A. A. Holder (1993). "Use of a recombinant baculovirus product to measure naturally-acquired human antibodies to disulphide-constrained epitopes on the P. falciparum merozoite surface protein-1 (MSP1)." Fems Immunol Med Microbiol 6(4): 307- 316. Blackman, M. J., J. A. Chappel et al. (1993). "A conserved parasite serine protease processes the Plasmodium falciparum merozoite surface protein-1." Mol Biochem Parasitol 62: 103-114. Blackman, M. J. (1994). "Purification of Plasmodium falciparum merozoites for analysis of the processing of merozoite surface protein-1. [Review]." Methods in Cell Biology 45: 213-20. Blackman, M. J., T. J. Scott-Finnigan et al. (1994). "Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein." J Exp Med 180(1): 389-93. Blackman, M. J., E. D. Dennis et al. (1996). "Plasmodium knowlesi: secondary processing of the malaria merozoite surface protein-1." Exp Parasitol 83(2): 229-39. Boyle, D. B., C. I. Newbold et al. (1982). "Monoclonal antibodies that protect in vivo against Plasmodium chabaudi recognize a 250,000-dalton parasite polypeptide." Infect Immun 38: 94-102. Braga, E. M., C. J. F. Fontes et al. (1998). "Persistence of humoral response against sporozoite and blood-stage malaria antigens 7 years after a brief exposure to Plasmodium vivax." J. Infect. Dis. 177(4): 1132-1135. Branch, O. H., V. Udhayakumar et al. (1998). "A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia." Am J Trop Med Hyg 58(2): 211-9. Braun, B. C., M. Jendoubi et al. (1986). "In vivo time course of synthesis and processing of major schizont membrane polypeptides in Plasmodium falciparum." Mol Biochem Parasitol 20: 33-43. Brockman, A., R. E. Paul et al. (1999). "Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand." Am J Trop Med Hyg 60(1): 14-21. Brown, K. N., W. Jarra et al. (1985). "Variability in parasite protein antigen structure and protective immunity to malaria." Ann Inst Pasteur Immunol 136: 11-23. Brown, J., H. C. Whittle et al. (1986). "Inhibition of Plasmodium falciparum growth by IgG antibody produced by human lymphocytes transformed with Epstein-Barr virus." Clin Exp Immunol 63: 135- 140. Brown, A. E., H. K. Webster et al. (1991). "Characterization of naturally acquired antibody responses to a recombinant fragment from the N-terminus of Plasmodium falciparum glycoprotein 195." Am J Trop Med Hyg 45(5): 567-573. Brown, K. N. (1991). "Protective immune responses as indicators of antigenic diversity and stability." Acta Leiden 60(1): 111-9. Brown, K. N. (1993). "Antigenic diversity, antigenic variation and merozoite surface protein 1. [Review]." Parassitologia 35: 13-5. Buranakitjaroen, P. and C. I. Newbold (1987). "Antigenic cross reactivity between p195 and a distinct protein of 100 kDa in Plasmodium falciparum." Mol Biochem Parasitol 22: 65-77. Burghaus, P. A. and A. A. Holder (1994). "Expression of the 19- kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein." Mol Biochem Parasitol 67(2): 343. Burghaus, P. A., B. T. Wellde et al. (1996). "Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection." Infect Immun 64(9): 3614-9. Burghaus, P. A., P. Gerold et al. (1999). "Analysis of recombinant merozoite surface protein-1 of Plasmodium falciparum expressed in mammalian cells." Mol. Biochem. Parasitol. 104(2): 171-183. Burns, J. J., T. M. Daly et al. (1988). "The 3' portion of the gene for a Plasmodium yoelii merozoite surface antigen encodes the epitope recognized by a protective monoclonal antibody." Proc Natl Acad Sci U S A 85: 602-606. Burns, J. J., W. R. Majarian et al. (1989). "A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii." J Immunol 143(8): 2670-6. Burns, J. M. J., L. A. Parke et al. (1989). "A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii." J Immunol 142: 2835-2840. Calvo, P. A., T. M. Daly et al. (1996). "Plasmodium yoelii: the role of the individual epidermal growth factor- like domains of the merozoite surface protein-1 in protection from malaria." Exp Parasitol 82(1): 54-64. Calvo, P. A., T. M. Daly et al. (1996). "Both epidermal growth factor like domains of the merozoite surface protein-1 from Plasmodium yoelii are required for protection from malaria." Annals N.Y. Acad. Sci. 797: 260-262. Camus, D., J. A. Lyon et al. (1987). "Characterization of gp195 processed products purified from Plasmodium falciparum culture supernates." Mol Biochem Parasitol 26: 21-27. Carvalho, L. H., C. J. Fontes et al. (1999). "Cellular responses to Plasmodium falciparum major surface antigens and their relationship to human activities associated with malaria transmission." Am J Trop Med Hyg 60(4): 674-9. Cavanagh, D. R. and J. S. McBride (1997). "Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1." Mol Biochem Parasitol 85(2): 197-211. Cavanagh, D. R., I. M. Elhassan et al. (1998). "A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan." J Immunol 161(1): 347-59. Certa, U., D. Rotmann et al. (1987). "A naturally occurring gene encoding the major surface antigen precursor p190 of Plasmodium falciparum lacks tripeptide repeats." EMBO J 6: 4137-4142. Certa, U. (1990). "Plasmodium falciparum surface antigen p190: Prevalence of a nonrepetitive allele in humans." Parasitol Today 6(12): 373-373. Chang, S. P., K. J. Kramer et al. (1988). "Plasmodium falciparum: gene structure and hydropathy profile of the major merozoite surface antigen (gp195) of the Uganda-Palo Alto isolate." Exp Parasitol 67: 1-11. Chang, S. P., G. S. Hui et al. (1989). "Generalized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum." Proc Natl Acad Sci U S A 86(6343): 6343- 6347. Chang, S. P., H. L. Gibson et al. (1992). "A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth." J. Immunol. 149: 548-555. Chang, S. P. (1994). "Expression systems that best mimic native structure: which ones to try first and why." Am J Trop Med Hyg 50(4 Suppl.): 11-19. Chang, S. P., C. M. Nikaido et al. (1994). "Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype." J Immunol 152(7): 3483-90. Chang, S. P., S. E. Case et al. (1996). "A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria." Infect Immun 64(1): 253-61. Chappel, J. A. and A. A. Holder (1993). "Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1." Mol Biochem Parasitol 60(2): 303-312. Chappel, J. A., A. F. Egan et al. (1994). "Naturally acquired human antibodies which recognize the first epidermal growth factor-like module in the plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro." Infect Immun 62(10): 4488-4494. Cheng, Q., A. Stowers et al. (1993). "Polymorphism in Plasmodium vivax MSA1 gene--The result of intragenic recombinations?" Parasitology 106(4): 335-345. Cheung, A., A. R. Shaw et al. (1985). "Cloning and expression in Escherichia coli of a surface antigen of Plasmodium falciparum merozoites." Embo J 4: 1007-1012. Cheung, A., J. Leban et al. (1986). "Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies." Proc Natl Acad Sci U S A 83: 8328-8332. Chitarra, V., I. Holm et al. (1999). "The crystal structure of C- terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate." Mol Cell 3(4): 457-64. Chulay, J. D., M. Aikawa et al. (1981). "Inhibitory effects of immune monkey serum on synchronized Plasmodium falciparum cultures." Am J Trop Med Hyg 30(12): 12-19. Collins, W. E., D. C. Kaslow et al. (1999). "Testing the efficacy of a recombinant merozoite surface protein (MSP-1(19)) of Plasmodium vivax in Saimiri boliviensis monkeys." Am. J. Trop. Med. Hyg. 60(3): 350-356. Conway, D. J. and J. S. McBride (1991). "Population genetics of Plasmodium falciparum within a malaria hyperendemic area." Parasitology 1(7): 7-16. Conway, D. J., V. Rosario et al. (1991). "Plasmodium falciparum: intragenic recombination and nonrandom associations between polymorphic domains of the precursor to the major merozoite surface antigens." Exp Parasitol 73(4): 469-80. Conway, D. J. and J. S. McBride (1991). "Genetic evidence for the importance of interrupted feeding by mosquitoes in the transmission of malaria." Trans R Soc Trop Med Hyg 85(4): 454-6. Conway, D., B. Greenwood et al. (1992). "Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population." Infect Immun 60(3): 1122-1127. Conway, D. J., C. Roper et al. (1999). "High recombination rate in natural populations of Plasmodium falciparum." Proc Natl Acad Sci U S A 96(8): 4506-11. Conway, D. J., C. Roper et al. (1999). "High recombination rate in natural populations of Plasmodium falciparum." Proc. Nat. Acad. Sci. USA 96(8): 4506-4511. Cooper, J. A. and H. Bujard (1992). "Membrane-associated proteases process Plasmodium falciparum merozoite surface antigen-1 (MSA1) to fragment gp41." Mol Biochem Parasitol 56(1): 151-160. Cooper, J. A., L. T. Cooper et al. (1992). "Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1." Mol Biochem Parasitol 51(2): 301-12. Cooper, J. A. (1993). "Merozoite surface antigen-1 of Plasmodium." Parasitol Today 9(2): 50-54. Crisanti, A., H. M. Muller et al. (1988). "Epitopes recognized by human T cells map within the conserved part of the GP190 of P. falciparum." Science 240: 1324-1326. Crisanti, A., K. Früh et al. (1990). "The T cell reactivity against the major merozoite protein of Plasmodium falciparum." Immunol Lett 25(1-3): 143-148. da Silveira, L. A., M. L. Dorta et al. (1999). "Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian Amazon region." Infect. Immunity 67(11): 5906-5916. Daly, T. M., J. J. Burns et al. (1989). "Precursor to the major merozoite surface antigen of Plasmodium yoelii: cloning and sequencing of the middle 1.9-kb region." Mol Biochem Parasitol 36(3): 283-5. Daly, T. M., J. M. Burns et al. (1992). "Comparison of the carboxy-terminal, cysteine-rich domain of the merozoite surface protein-1 from several strains of Plasmodium yoelii." Mol Biochem Parasitol 52(2): 279-282. Daly, T. M. and C. A. Long (1993). "A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice." Infect Immun 61(6): 2462-7. Daly, T. M. and C. A. Long (1995). "Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria." J Immunol 155(1): 236-43. Daly, T. M. and C. A. Long (1996). "Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection." Infect Immun 64(7): 2602-8. Daubersies, P., S. Sallenave-Sales et al. (1996). "Rapid turnover of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area." Am J Trop Med Hyg 54(1): 18- 26. David, P. H., T. J. Hadley et al. (1984). "Processing of a major parasite surface glycoprotein during the ultimate stages of differentiation in Plasmodium knowlesi." Mol Biochem Parasitol 11: 267-282. de Oliveira, C. I., G. Wunderlich et al. (1999). "Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax." Vaccine 17(23-24): 2959-2968. del Portillo, H., J. Gysin et al. (1988). "Plasmodium vivax: cloning and expression of a major blood-stage surface antigen." Exp Parasitol 67(346): 346-353. del Portillo, H., S. Longacre et al. (1991). "Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species." Proc Natl Acad Sci Usa 88(9): 4030-4034. del Portillo, H. A., G. Levitus et al. (1992). "Human IgG responses against the N-terminal region of the Merozoite Surface Protein 1 of Plasmodium vivax." Memorias do Instituto Oswaldo Cruz 3: 77-84. Deleersnijder, W., D. Hendrix et al. (1990). "Molecular cloning and sequence analysis of the gene encoding the major merozoite surface antigen of Plasmodium chabaudi chabaudi IP-PC1." Mol Biochem Parasitol 43(2): 231-244. Deleersnijder, W., D. Hendrix et al. (1991). "Analysis of MSA-1 diversity in Plasmodium chabaudi chabaudi strains." Mol Biochem Parasitol 46(2): 315-318. Diallo, T. O., C. M. Nguer et al. (1999). "Immune responses to P. falciparum-MSP1 antigen: lack of correlation between antibody responses and the capacity of peripheral cellular immune effectors to respond to this antigen in vitro." Immunol. Lett. 67(3): 217- 221. Dieye, A., J. L. Sarthou et al. (1993). "[Analysis of the antibody response to merozoite antigens in a malaria holoendemic area]." Dakar Med 38(2): 169-74. Diggs, C. L., W. R. Ballou et al. (1993). "The major merozoite surface protein as a malaria vaccine target." Parasitol Today 9(8): 300-302. Dodoo, D., T. G. Theander et al. (1999). "Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria." Infect Immun 67(5): 2131-7. Drager-Dayal, R., C. Decrind et al. (1992). "Plasmodium falciparum synthesizes ortho glycosylated Glycoproteins containing ortho- linked N-acetylglucosamine." Biochem. Int. 27: 55-64. Duque, S., S. Montenegro-James et al. (1998). "Expression of cytokine genes in Aotus monkeys immunized with synthetic and recombinant Plasmodium vivax and P. falciparum antigens." Ann Trop Med Parasitol 92(5): 553-9. Dyal, R., C. Decrind et al. (1986). "Comparison of asexual blood- stage antigens of Plasmodium falciparum recognized by antibody reagents from nine laboratories." Bull Who 64: 403-414. Eamsila, C., P. Singharaj et al. (1993). "Prevention of Plasmodium falciparum malaria by Fansimef and Lariam in the northeastern part of Thailand." Southeast Asian J Trop Med Public Health 24(4): 672- 6. Egan, A. F., J. A. Chappel et al. (1995). "Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy- terminal fragment of the major merozoite surface protein of plasmodium falciparum." Infect Immun 63(2): 456-466. Egan, A., M. Waterfall et al. (1997). "Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T- cell recognition of polypeptides with numerous disulfide bonds." Infect Immun 65(8): 3024-31. Egan, A. F., P. Burghaus et al. (1999). "Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro." Parasite Immunol 21(3): 133-9. Epstein, N., L. H. Miller et al. (1981). "Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasion." J Immunol 127: 212-217. Escalante, A. A., A. A. Lal et al. (1998). "Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum." Genetics 149(1): 189-202. Etlinger, H. M., P. Caspers et al. (1991). "Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum." Infect Immun 59(10): 3498- 3503. Etlinger, H. M. (1992). "Carrier sequence selection - one key to successful vaccines." Immunol. Today 13: 52-55. Farley, P. J., R. Srivastava et al. (1994). "Sequence of the gene encoding the N-terminal portion of the plasmodium yoelii yoelii 17XL merozoite surface protein-1 (MSP-1)." Gene 151(1-2): 335-336. Farley, P. and C. Long (1995). "Plasmodium yoelii yoelii 17XL MSP- 1: Fine-specificity mapping of a discontinuous, disulfide- dependent epitope recognized by a protective monoclonal antibody using expression PCR (E-PCR)." Exp Parasitol 80: 328-332. Farnert, A., G. Snounou et al. (1997). "Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area." Am J Trop Med Hyg 56(5): 538-47. Farnert, A., I. Rooth et al. (1999). "Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children." J Infect Dis 179(4): 989- 95. Ferreira, M. U., Q. Liu et al. (1998). "Allelic diversity in the merozoite surface protein-1 and epidemiology of multiple-clone Plasmodium falciparum infections in northern Tanzania." J Parasitol 84(6): 1286-9. Ferreira, M. U., O. Kaneko et al. (1998). "Allelic diversity at the merozoite surface protein-1 (MSP-1) locus in natural Plasmodium falciparum populations: a brief overview." Mem Inst Oswaldo Cruz 93(5): 631-8. Ferreira, M. U., Q. Liu et al. (1998). "Stable patterns of allelic diversity at the merozoite surface protein-1 locus of Plasmodium falciparum in clinical isolates from southern Vietnam." J. Eukaryot. Microbiol. 45(1): 131-136. Ferreira, M. U., Q. Liu et al. (1998). "Allelic diversity at the merozoite surface protein-1 locus of Plasmodium falciparum in clinical isolates from the southwestern Brazilian Amazon." Am. J. Trop. Med. Hyg. 59(3): 474-480. Fraser, T., P. Michon et al. (1997). "Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein." Infect Immun 65(7): 2772-7. Freeman, R. R., A. J. Trejdosiewicz et al. (1980). "Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite." Nature 284: 366-368. Freeman, R. R., A. A. Holder et al. (1980). Monoclonal antibodies against the rodent malaria parasite, Plasmodium yoelii. The host invader interplay. H. V. d. B. J. R. Foundation. Elsevier/N.Holland Biomed.Press, Elsevier/N.Holland Biomed.Press. Freeman, R. R. and A. A. Holder (1983). "Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen." Clin Exp Immunol 54: 609-616. Freeman, R. R. and A. A. Holder (1983). "Surface antigens of malaria merozoites. A high molecular weight precursor is processed to an 83,000 molecular weight form expressed on the surface of Plasmodium falciparum merozoites." J. Exp. Med. 158: 1647-1653. Fruh, K., H. M. Muller et al. (1989). "A new tool for the serodiagnosis of acute Plasmodium falciparum malaria in individuals with primary infection." J Immunol Methods 122(25): 25-32. Früh, K., O. Doumbo et al. (1991). "Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived." Infect Immun 59(4): 1319-1324. Furtado, G. C., I. C. Moura et al. (1999). "Plasmodium chabaudi chabaudi: a monoclonal antibody raised against soluble antigens present in the plasma of infected mice recognizes a 250-kDa schizont glycoprotein that is secreted during schizogony." Exp Parasitol 91(1): 97-100. Garraud, O., A. Diouf et al. (1999). "Different Plasmodium falciparum recombinant MSP1(19) antigens differ in their capacities to stimulate in vitro peripheral blood T lymphocytes in individuals from various endemic areas." Scand J Immunol 49(4): 431-40. Garraud, O., A. Diouf et al. (1999). "Immune responses to Plasmodium falciparum-merozoite surface protein 1 (MSP1) antigen, II. Induction of parasite-specific immunoglobulin G in unsensitized human B cells after in vitro T-cell priming with MSP119." Immunology 97(3): 497-505. Genton, B., F. Al-Yaman et al. (1998). "Relation of anthropometry to malaria morbidity and immunity in Papua New Guinean children." Am. J. Clin. Nutr. 68(3): 734-741. Gentz, R., U. Certa et al. (1988). "Major surface antigen p190 of Plasmodium falciparum: detection of common epitopes present in a variety of plasmodia isolates :published erratum appears in EMBO J 1988 May;7(5):1558:." EMBO J 7: 225-230. Gibson, H. L., J. E. Tucker et al. (1992). "Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax." Mol Biochem Parasitol 50(2): 325-33. Gozalo, A., C. Lucas et al. (1998). "Passive transfer of growth- inhibitory antibodies raised against yeast- expressed recombinant Plasmodium falciparum merozoite surface protein- 1(19)." Am J Trop Med Hyg 59(6): 991-7. Green, T. J., M. Morhardt et al. (1981). "Serum inhibition of merozoite dispersal from Plasmodium falciparum schizonts: indicator of immune status." Infect Immun 31(1203): 1203-1208. Grifantini, R., O. Finco et al. (1998). "Multi-plasmid DNA vaccination avoids antigenic competition and enhances immunogenicity of a poorly immunogenic plasmid." Eur. J. Immunol. 28(4): 1225-1232. Guevara Patino, J. A., A. A. Holder et al. (1997). "Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies." J Exp Med 186(10): 1689-99. Guttinger, M., P. Romagnoli et al. (1991). "HLA polymorphism and T cell recognition of a conserved region of p190, a malaria vaccine candidate." Int Immunol 3(9): 899-906. Haddad, D., G. Snounou et al. (1999). "Limited genetic diversity of Plasmodium falciparum in field isolates from Honduras." Am J Trop Med Hyg 60(1): 30-4. Haldar, K., M. A. Ferguson et al. (1985). "Acylation of a Plasmodium falciparum merozoite surface antigen via sn-1,2-diacyl glycerol." J Biol Chem 260: 4969-4974. Hall, R., J. McBride et al. (1983). "Antigens of the erythrocytic stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies." Molec Biochem Parasitol 7: 247-265. Hall, R., J. E. Hyde et al. (1984). "Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria." Nature 311: 379-382. Hall, R., A. Osland et al. (1984). "Processing, polymorphism, and biological significance of P190, a major surface antigen of the erythrocytic forms of Plasmodium falciparum." Mol Biochem Parasitol 11: 61-80. Haywood, M., D. J. Conway et al. (1999). "The epidemiology of multiple Plasmodium falciparum infections - 12. Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66." Trans. Roy. Soc. Trop. Med. Hyg. 93: S65-S68. Heidrich, H. G., W. Strych et al. (1983). "Identification of surface and internal antigens from spontaneously released Plasmodium falciparum merozoites by radio-iodination and metabolic labelling." Z Parasitenkd 69: 715-725. Heidrich, H. G., W. Strych et al. (1984). "Spontaneously released Plasmodium falciparum merozoites from culture possess glycoproteins." Z Parasitenkd 70: 747-751. Heidrich, H. G., M. Matzner et al. (1986). "Immunoelectron microscopy shows that the 80,000-dalton antigen of Plasmodium falciparum merozoites is localized in the surface coat." Z Parasitenkd 72(681): 681-683. Heidrich, H. G., B. A. Miettinen et al. (1989). "The N-terminal amino acid sequences of the Plasmodium falciparum (FCB1) merozoite surface antigens of 42 and 36 kilodalton, both derived from the 185-195-kilodalton precursor." Mol Biochem Parasitol 34: 147-154. Herrera, S., M. A. Herrera et al. (1990). "Immunization of Aotus monkeys with Plasmodium falciparum blood-stage recombinant proteins." Proc Natl Acad Sci U S A 87(10): 4017-21. Herrera, M. A., F. Rosero et al. (1992). "Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection." Infect Immun 60(1): 154- 8. Herrera, S., W. Rudin et al. (1993). "A conserved region of the MSP-1 surface protein of Plasmodium falciparum contains a recognition sequence for erythrocyte spectrin." Embo J 12(4): 1607-14. Hirunpetcharat, C., J. H. Tian et al. (1997). "Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells." J Immunol 159(7): 3400-11. Hirunpetcharat, C., D. Stanisic et al. (1998). "Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in mice." Parasite Immunol 20(9): 413-20. Hirunpetcharat, C., P. Vukovic et al. (1999). "Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1." J Immunol 162(12): 7309-14. Hogh, B., N. T. Marbiah et al. (1995). "Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk of infection and disease in infants living in an area of Liberia, west Africa, in which malaria is highly endemic." Infection & Immunity 63(10): 4034-8. Hogh, B. (1996). "Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children." Scand J Infect Dis Suppl 102: 1-53. Holder, A. A. and R. R. Freeman (1981). "Immunization against blood-stage rodent malaria using purified parasite antigens." Nature 294(361): 361-364. Holder, A. A. and R. R. Freeman (1982). "Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody." J Exp Med 156(1528): 1528-1538. Holder, A. A., R. R. Freeman et al. (1983). "Serological cross- reaction between high molecular weight proteins synthesized in blood schizonts of Plasmodium yoelii, Plasmodium chabaudi and Plasmodium falciparum." Mol Biochem Parasitol 9(191): 191-196. Holder, A. A. and R. R. Freeman (1984). "Protective antigens of rodent and human bloodstage malaria." Philos Trans R Soc Lond :Biol. Holder, A. A. and R. R. Freeman (1984). "The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor." J Exp Med 160(624): 624-629. Holder, A. A. and R. R. Freeman (1984). "Characterization of a high molecular weight protective antigen of Plasmodium yoelii." Parasitology 88(211): 211-219. Holder, A. A., M. J. Lockyer et al. (1985). "Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites." Nature 317(270): 270-273. Holder, A. A., J. S. Sandhu et al. (1987). "Processing of the precursor to the major merozoite surface antigens of Plasmodium falciparum." Parasitology 94(199): 199-208. Holder, A. A., Y. Hillman et al. (1987). Studies of the Plasmodium falciparum 195,000 molecular mass merozoite surface antigen precursor. Host parasite cellular and molecular interactions in protozoal infections. K. P. Chang and D. Snary. Berlin/Heidelberg, Springer-Verlag. Holder, A. A., M. J. Lockyer et al. (1988). "A hybrid gene to express protein epitopes from both sporozoite and merozoite surface antigens of Plasmodium falciparum." Parasitology 97(373): 373-382. Holder, A. A., R. R. Freeman et al. (1988). "Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli." Parasite Immunol 10(607): 607-617. Holder, A. A. (1988). "The precursor to major merozoite surface antigens: structure and role in immunity." Prog Allergy 41: 72-97. Holder, A. A., M. J. Blackman et al. (1992). "A malaria merozoite surface protein (MSP1)-structure, processing and function." Mem Inst Oswaldo Cruz 87(Suppl 3): 37-42. Holder, A. A. (1994). "Proteins on the surface of the malaria parasite and cell invasion." Parasitology 108( Suppl.): S5-S18. Holder, A. A., M. J. Blackman et al. (1994). "Malaria parasites and erythrocyte invasion." Biochem Soc Trans 22: 291-295. Holder, A. A. and M. J. Blackman (1994). "What is the function of MSP-1 on the malaria merozoite." Parasitol Today 10(5): 182-184. Holder, A. A. and E. M. Riley (1996). "Human immune response to MSP-I." Parasitol Today 12(5): 173-174. Howard, R. J., J. A. Lyon et al. (1984). "Localization of the major Plasmodium falciparum glycoprotein on the surface of mature intraerythrocytic trophozoites and schizonts." Mol Biochem Parasitol 11: 349-362. Howard, R. F., H. A. Stanley et al. (1985). "Two Plasmodium falciparum merozoite surface polypeptides share epitopes with a single Mr 185 000 parasite glycoprotein." Mol Biochem Parasitol 17: 61-77. Howard, R. F., F. Ardeshir et al. (1986). "Conservation and antigenicity of N-terminal sequences of GP185 from different Plasmodium falciparum isolates." Gene 46: 197-205. Howard, R. J., J. S. McBride et al. (1986). "Antigenic diversity and size diversity of Plasmodium falciparum antigens in isolates from Gambian patients. II. the schizont surface glycoprotein of molecular weight approximately 200 000." Parasite Immunol 8: 57- 68. Howard, R. F., F. Ardeshir et al. (1987). DNA sequence analysis of cDNA clones for the Mr 185,000 glycoprotein of Plasmodium falciparum. New York, Alan R Liss Inc. Huber, W., H. Haji et al. (1998). "Genetic characterization of the malaria parasite Plasmodium falciparum in the transmission from the host to the vector." Parasitology 116(Pt 2): 95-101. Hudson, D. E., L. H. Miller et al. (1983). "The malarial merozoite surface: a 140,000 MW protein antigenically unrelated to other surface components on Plasmodium knowlesi merozoites." J Immunol 130: 2886-2890. Hughes, A. L. (1992). "Positive selection and interallelic recombination at the merozoite surface antigen-1 (MSA-1) locus of Plasmodium falciparum." Mol Biol Evol 9(3): 381-93. Hughes, A. L. and F. Verra (1998). "Ancient polymorphism and the hypothesis of a recent bottleneck in the malaria parasite Plasmodium falciparum [letter]." Genetics 150(1): 511-3. Hui, G. S. and W. A. Siddiqui (1987). "Serum from Pf195 protected Aotus monkeys inhibit Plasmodium falciparum growth in vitro." Exp Parasitol 64: 519-522. Hui, G., S. P. Chang et al. (1991). "Influence of adjuvants on the antibody specificity to the Plasmodium falciparum major merozoite surface protein, gp195." J Immunol 147(11): 3935-3941. Hui, G., L. Q. Tam et al. (1991). "Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195." Infect Immun 59(5): 1585-1591. Hui, G. S., A. Hashimoto et al. (1992). "Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum." Infect Immun 60(4): 1422-33. Hui, G. S. N. and S. P. Chang (1992). "Plasmodium-falciparum - induction of biologically active antibodies to gp195 is dependent on the choice of adjuvants." Exp. Parasitol. 75: 155-157. Hui, G., C. Hashiro et al. (1993). "Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus." Infect Immun 61(8): 3403-3411. Hui, G. S. N., W. L. Gosnell et al. (1994). "Immunogenicity of the c-terminal 19kDa fragment of the plasmodium falciparum - merozoite surface protein 1 (MSP1), YMSP119 expressed in s.cerevisiae." J Immunol 153(6): 2544-2553. Hui, G. S. N., A. C. Hashimoto et al. (1994). "Induction of antibodies to the plasmodium falciparum merozoite surface protein- 1 (MSP1) by cross-priming with heterologous MSP1s." J Immunol 153(3): 1195-1201. Hui, G. S., C. Nikaido et al. (1996). "Dominance of conserved B- cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys." Infect Immun 64(5): 1502-9. Hui, G. S. and C. N. Hashimoto (1998). "Pathways for potentiation of immunogenicity during adjuvant-assisted immunizations with Plasmodium falciparum major merozoite surface protein 1." Infect Immun 66(11): 5329-36. Jakobsen, P. H., R. Moon et al. (1993). "Tumour necrosis factor and interleukin-6 production induced by components associated with merozoite proteins of Plasmodium falciparum." Parasite Immunol 15(4): 229-37. Jakobsen, P. H., L. Hviid et al. (1993). "Specific T-cell recognition of the merozoite proteins rhoptry- associated protein 1 and erythrocyte-binding antigen 1 of Plasmodium falciparum." Infect Immun 61(1): 268-73. Jelinek, T., S. Proll et al. (1996). "Geographic differences in the sensitivity of a polymerase chain reaction for the detection of Plasmodium falciparum infection." Am J Trop Med Hyg 55(6): 647- 51. Jennings, G. J., C. S. Toebe et al. (1998). "The complete sequence of Plasmodium berghei merozoite surface protein-1 and its inter- and intra-species variability." Mol. Biochem. Parasitol. 93(1): 43-55. Jiang, G. F., C. Daubenberger et al. (2000). "Sequence diversity of the merozoite surface protein 1 of Plasmodium falciparum in clinical isolates from the Kilombero District, Tanzania." Acta Trop. 74(1): 51-61. Johnson, J. G., N. Epstein et al. (1981). "Identification of surface proteins on viable Plasmodium knowlesi merozoites." J Protozool 28: 160-164. Jongwutiwes, S., K. Tanabe et al. (1991). "Coexistence of GP195 alleles of Plasmodium falciparum in a small endemic area." Am J Trop Med Hyg 44(3): 299-305. Jongwutiwes, S., K. Tanabe et al. (1992). "Sequence variation in the tripeptide repeats and T cell epitopes in P190 (MSA-1) of Plasmodium falciparum from field isolates." Mol Biochem Parasitol 51: 81-. Jongwutiwes, S., K. Tanabe et al. (1993). "Sequence conservation in the C-terminal part of the precursor to the major merozoite surface proteins (MSP1) of Plasmodium falciparum from field isolates." Mol Biochem Parasitol 59(1): 95-100. Kabilan, L., V. P. Sharma et al. (1994). "Cellular and humoral immune responses to well defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic." Infect Immun 62(2): 685- 691. Kamber, M., M. Blackman et al. (1992). "Human monoclonal antibodies against Plasmodium falciparum: production, stabilization and characterization." Parasite Immunol 14(4): 451- 6. Kaneko, O., S. Jongwutiwes et al. (1996). "Plasmodium falciparum: variation in block 4 of the precursor to the major merozoite surface proteins in natural populations." Exp. Parasitol. 84(1): 92-95. Kaneko, O., M. Kimura et al. (1997). "Plasmodium falciparum: allelic variation in the merozoite surface protein 1 gene in wild isolates from southern Vietnam." Exp. Parasitol. 86(1): 45-57. Kang, Y. and C. A. Long (1995). "Sequence heterogeneity of the C- terminal, Cys-rich region of the merozoite surface protein-1 (MSP- 1) in field samples of Plasmodium falciparum." Mol Biochem Parasitol 73(1-2): 103-10. Kang, Y. and C. A. Long (1996). "Sequence studies on the COOH- terminal region of the merozoite surface protein-1 in field samples of Plasmodium falciparum from diverse geographic areas." Annals N. Y. Acad. Sci. 797: 282-284. Kang, Y., P. A. Calvo et al. (1998). "Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite." J Immunol 161(8): 4211-9. Kaslow, D. C., G. Hui et al. (1994). "Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP1 (19)) variants secreted from Saccharomyces cerevisiae." Mol Biochem Parasitol 63: 283-289. Kataaha, P. K., C. A. Facer et al. (1984). "Plasmodium falciparum products enhance human lymphocyte transformation by Epstein-Barr virus." Clin Exp Immunol 56: 371-376. Keitel, W. A., K. E. Kester et al. (2000). "Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein I (msp-119) and T helper epitopes of tetanus toxoid." Vaccine 18(5-6): 531-539. Kemp, D. J., R. L. Coppel et al. (1986). "The Wellcome Trust lecture. Genes for antigens of Plasmodium falciparum." Parasitology 91: S83-S108. Kemp, D. J., R. L. Coppel et al. (1987). "Repetitive proteins and genes of malaria." Ann Rev Microbiol 41: 181-208. Kemp, D. J., A. F. Cowman et al. (1990). "Genetic diversity in Plasmodium falciparum." Adv Parasitol 29(75): 75-149. Kerr, P. J., L. C. Ranfordcartwright et al. (1994). "Proof of intragenic recombination in Plasmodium falciparum." Mol Biochem Parasitol 66(2): 241-248. Khurana, S. K. and V. H. Talib (1996). "Malaria vaccine." Indian J Pathol Microbiol 39(5): 433-41. Kimura, E., D. Mattei et al. (1990). "Genetic diversity in the major merozoite surface antigen of Plasmodium falciparum: High prevalence of a third polymorphic form detected in strains derived from malaria patients." Gene 91(1): 57-62. Kirchgatter, K. and H. A. del Portillo (1998). "Molecular analysis of Plasmodium vivax relapses using the MSP1 molecule as a genetic marker." J Infect Dis 177(2): 511-5. Kitua, A. Y., H. Urassa et al. (1999). "Antibodies against plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationships with clinical malaria and with entomological inoculation rates [In Process Citation]." Parasite Immunol 21(6): 307-17. Kitua, A. Y., H. Urassa et al. (1999). "Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationships with clinical malaria and with entomological inoculation rates." Parasite Immunol. 21(6): 307-317. Kolakovich, K. A., A. Ssengoba et al. (1996). "Plasmodium vivax: favored gene frequencies of the merozoite surface protein-1 and the multiplicity of infection in a malaria endemic region." Exp Parasitol 83(1): 11-9. Konaté, L., J. Zwetyenga et al. (1999). "The epidemiology of multiple Plasmodium falciparum infections - 5. Variation of Plasmodium falciparum msp1 block 2 and msp2 allele prevalence and of infection complexity in two neighbouring Senegalese villages with different transmission conditions." Trans. Roy. Soc. Trop. Med. Hyg. 93: S21-S28. Kramer, K. J. and R. Oberst (1992). "Antibodies to the major merozoite surface coat protein of Plasmodium falciparum (gp195) in a human population living in a malaria-endemic area of the Philippines." Am J Trop Med Hyg 47(4): 429-39. Kumar, A., R. Arora et al. (1992). ""Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide." J Immunol 148(5): 1499-505. Kumar, S., A. Yadava et al. (1995). "Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys." Mol Med 1(3): 325-32. Kun, J. F. J., R. J. Schmidt-Ott et al. (1998). "Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon." Trans. R. Soc. Trop. Med. Hyg. 92(1): 110-114. Kyes, S., R. Harding et al. (1997). "Limited spatial clustering of individual Plasmodium falciparum alleles in field isolates from coastal Kenya." Am J Trop Med Hyg 57(2): 205-15. Lalitha, P. V., P. Malhotra et al. (1999). "Plasmodium falciparum: variations in the C-terminal cysteine-rich region of the merozoite surface protein-1 in field samples among Indian isolates." Exp Parasitol 92(1): 12-8. Laserson, K. F., I. Petralanda et al. (1999). "Genetic characterization of an epidemic of Plasmodium falciparum malaria among Yanomami Amerindians." J. Infec. Dis. 180(6): 2081-2085. Lawrence, G., Q. Cheng et al. (2000). "Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers." Vaccine 18(18): 1925-1931. Levitus, G., F. Mertens et al. (1994). "Characterization of naturally acquired human IgG responses against the N-terminal region of the merozoite surface protein 1 of Plasmodium vivax." Am J Trop Med Hyg 51(1): 68-76. Levitus, G. and H. A. del Portillo (1994). "Advances toward the development of an asexual blood stage MSP-1 vaccine of Plasmodium vivax." Mem Inst Oswaldo Cruz 89(Suppl 2): 81-4. Levitus, G., F. Mertens et al. (1997). "Plasmodium vivax: epitope mapping of monoclonal antibodies against the N-terminal region of the merozoite surface protein 1." Behring Inst Mitt(99): 107-11. Lew, A. M., C. J. Langford et al. (1989). "A protective monoclonal antibody recognizes a linear epitope in the precursor to the major merozoite antigens of Plasmodium chabaudi adami." Proc Natl Acad Sci U S A 86(3768): 3768-3772. Lew, A. M., D. J. Beck et al. (1990). "A second region recognized by the protective monoclonal antibody 5C10/66 in the precursor to the major merozoite surface antigen of Plasmodium chabaudi adami." Mol Biochem Parasitol 41(2): 289-292. Lew, A. M. and D. J. Beck (1990). "The epitope of a protective monoclonal antibody occurs in a region of microheterogeneity in Plasmodium chabaudi." Mol Biochem Parasitol 42(1): 153-154. Lewis, A. P. (1989). "Cloning and analysis of the gene encoding the 230-kilodalton merozoite surface antigen of Plasmodium yoelii." Mol Biochem Parasitol 36(3): 271-82. Lewis, A. P. (1990). "Sequence analysis upstream of the gene encoding the precursor to the major merozoite surface antigens of Plasmodium yoelii." Mol Biochem Parasitol 39(2): 285-8. Ling, I. T., S. A. Ogun et al. (1994). "Immunization against malaria with a recombinant protein." Parasite Immunol 16(2): 63- 67. Ling, I. T., S. A. Ogun et al. (1995). "The combined epidermal growth factor-like modules of Plasmodium yoelii Merozoite Surface Protein-1 are required for a protective immune response to the parasite." Parasite Immunol 17(8): 425-33. Ling, I. T., S. A. Ogun et al. (1997). "Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use." Vaccine 15(14): 1562-7. Locher, C. P. and L. Q. Tam (1993). "Reduction of disulfide bonds in Plasmodium falciparum gp195 abolishes the production of growth- inhibitory antibodies." Vaccine 11(11): 1119-1123. Locher, C. P. and L. Q. Tam (1994). "Reduction of disulfide bonds in plasmodium falciparum gp195 abolishes the production of Growth- Inhibitory antibodies (Vol 11, pg 1119, 1993)." Vaccine 12(4): 382. Lockyer, M. J., H. Cooper et al. (1993). "Immunogenicity of a hybrid Plasmodium falciparum malaria antigen." Parasitology 106(5): 451-457. Long, C. A., T. M. Daly et al. (1994). "Immunity to erythrocytic stages of malarial parasites. [Review]." American Journal of Tropical Medicine & Hygiene 50(4 Suppl): 27-32. Longacre, S., K. N. Mendis et al. (1994). "Plasmodium vivax merozoite surface protein 1 C-terminal recombinant proteins in baculovirus." Molecular & Biochemical Parasitology 64(2): 191-205. Lozano, J. M., F. Espejo et al. (1998). "Reduced amide pseudopeptide analogues of a malaria peptide possess secondary structural elements responsible for induction of functional antibodies which react with native proteins expressed in Plasmodium falciparum erythrocyte stages." J Pept Res 52(6): 457- 69. Luty, A. J. F., B. Lell et al. (1999). "Interferon-g responses are associated with resistance to reinfection with Plasmodium falciparum in young African children." J. Infect. Dis. 179(4): 980-988. Lyon, J. A., R. H. Geller et al. (1986). "Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene." Proc Natl Acad Sci U S A 83: 2989-2993. Lyon, J. A., J. D. Haynes et al. (1986). "Plasmodium falciparum antigens synthesized by schizonts and stabilized at the merozoite surface by antibodies when schizonts mature in the presence of growth inhibitory immune serum." J Immunol 136: 2252-2258. Lyon, J. A. and J. D. Haynes (1986). "Plasmodium falciparum antigens synthesized by schizonts and stabilized at the merozoite surface when schizonts mature in the presence of protease inhibitors." J Immunol 136: 2245-2251. Lyon, J. A., J. D. Haynes et al. (1987). "Monoclonal antibody characterization of the 195-kilodalton major surface glycoprotein of Plasmodium falciparum malaria schizonts and merozoites: identification of additional processed products and a serotype- restricted repetitive epitope." J Immunol 138: 895-901. Lyon, J. A., A. W. Thomas et al. (1989). "Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes." Mol Biochem Parasitol 36: 77-86. Lyon, J. A., J. M. Carter et al. (1997). "Merozoite surface protein-1 epitopes recognized by antibodies that inhibit Plasmodium falciparum merozoite dispersal." Mol Biochem Parasitol 90(1): 223-34. Mackay, M., M. Goman et al. (1985). "Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level." Embo J 4: 3823-3829. Majarian, W. R., T. M. Daly et al. (1984). "Passive immunization against murine malaria with an IgG3 monoclonal antibody." J Immunol 132: 3131-3137. Majarian, W. R., T. M. Daly et al. (1988). "Plasmodium yoelii: characterization of a protective idiotype during malarial infection in mice." Exp. Parasitol. 67: 227-237. Mancilla, L. I., G. Levitus et al. (1994). "Plasmodium vivax: dimorphic DNA sequences from the MSP-1 gene code for regions that are immunogenic in natural infections." Exp Parasitol 79(2): 148- 58. Masinde, G. L., D. J. Krogstad et al. (1998). "Immunization with SPf66 and subsequent infection with homologous and heterologous Plasmodium falciparum parasites." Am J Trop Med Hyg 59(4): 600-5. Matsumoto, S., H. Yukitake et al. (1998). "Recombinant Mycobacterium bovis bacillus Calmette-Guerin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies." J Exp Med 188(5): 845-54. Matsumoto, S., H. Yukitake et al. (2000). "Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting merozoite surface protein-1." Vaccine 18(9-10): 832-834. McBride, J. S., D. Walliker et al. (1982). "Antigenic diversity in the human malaria parasite Plasmodium falciparum." Science 217: 254-257. McBride, J. S., P. D. Welsby et al. (1984). "Serotyping Plasmodium falciparum from acute human infections using monoclonal antibodies." Trans Roy Soc Trop Med Hyg 78: 32-34. McBride, J. S., C. I. Newbold et al. (1985). "Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum." J Exp Med 161: 160-180. McBride, J. S. and H. G. Heidrich (1987). "Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex." Mol Biochem Parasitol 23: 71-84. McGarvey, M. J., E. Sheybani et al. (1984). "Identification and expression in Escherichia coli of merozoite stage-specific genes of the human malarial parasite Plasmodium falciparum." Proc Natl Acad Sci U S A 81: 3690-3694. McGuinness, D., S. Bennett et al. (1997). "Statistical analysis of highly skewed immune response data." J Immunol Methods 201(1): 99- 114. Mckean, P. G., K. Odea et al. (1993). "A Single Amino Acid Determines the Specificity of a Monoclonal Antibody Which Inhibits Plasmodium Chabaudi as in Vivo." Mol Biochem Parasitol 62: 211- 221. McKean, P. G., K. O'Dea et al. (1993). "Nucleotide sequence analysis and epitope mapping of the merozoite surface protein 1 from Plasmodium chabaudi chabaudi AS." Mol Biochem Parasitol 62(2): 199-209. McLean, A. P., F. A. Lainson et al. (1991). "Genetic studies on a major merozoite surface antigen of the malaria parasite of rodents, Plasmodium chabaudi." Parasite Immunol 13(4): 369-378. Mercereau-Puijalon, O., T. Fandeur et al. (1991). "A study of the genomic diversity of Plasmodium falciparum in Senegal. 2 Typing by the use of the polymerase chain reaction." Acta Trop Basel 49(4): 293-304. Mercereau-Puijalon, O. (1996). "Revisiting host/parasite interactions: molecular analysis of parasites collected during longitudinal and cross-sectional surveys in humans." Parasite Immunol 18(4): 173-80. Mertens, F., G. Levitus et al. (1993). "Longitudinal Study of Naturally Acquired Humoral Immune Responses Against the Merozoite Surface Protein-1 of Plasmodium-Vivax in Patients from Rondonia, Brazil." Am J Trop Med Hyg 49: 383-392. Migot-Nabias, F., A. J. F. Luty et al. (1999). "Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children." Am. J. Trop. Med. Hyg. 61(3): 488-494. Miller, L. H., J. G. Johnson et al. (1980). "Determinants on surface proteins of Plasmodium knowlesi merozoites common to Plasmodium falciparum schizonts." J Exp Med 151: 790-798. Miller, L. H., T. Roberts et al. (1993). "Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1)." Mol Biochem Parasitol 59(1): 1-14. Molano, A., C. Segura et al. (1992). "In human malaria protective antibodies are directed mainly against the Lys-Glu ion pair within the Lys-Glu-Lys motif of the synthetic vaccine SPf66." Parasit Immunol 14: 111-124. Morgan, W. D., B. Birdsall et al. (1999). "Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1." J. Mol. Biol. 289(1): 113-122. Muller, H. M., K. Fruh et al. (1989). "Development of the human immune response against the major surface protein (gp190) of Plasmodium falciparum." Infect Immun 57(12): 3765-9. Murphy, V. F., W. C. Rowan et al. (1990). "Expression of hybrid malaria antigens in insect cells and their engineering for correct folding and secretion." Parasitology 2(177): 177-83. Myler, P. J. (1989). "Nucleotide and deduced amino acid sequence of the gp195 (MSA-1) gene from Plasmodium falciparum Palo Alto PLF-3/B11." Nucleic Acids Res 17(5401): 5401-5401. Myler, P. J. (1990). "Transcriptional analysis of the major merozoite surface antigen precursor (gp195) gene of Plasmodium falciparum." Parasites 130: 123-137. Nambei, W. S., M. Goumbala et al. (1998). "Imbalanced distribution of IgM and IgG antibodies against Plasmodium falciparum antigens and merozoite surface protein-1 (MSP1) in pregnancy." Immunol Lett 61(2-3): 197-9. Nasir-Ud-Din, R. Drager-Dayal et al. (1992). "Plasmodium falciparum synthesizes O glycosylated glycoproteins containing O- linked Nacetylglucosamine." Biochem. Int 27: 55-64. Newbold, C. I. (1981). "Identification of surface antigens of the asexual erythrocytic cycle of malaria parasites." Biochem Soc Trans 9: 534-534. Newbold, C. I., D. B. Boyle et al. (1982). "Identification of a schizont- and species-specific surface glycoprotein on erythrocytes infected with rodent malarias." Mol Biochem Parasitol 5: 45-54. Newbold, C. I., D. B. Boyle et al. (1982). "Stage specific protein and nucleic acid synthesis during the asexual cycle of the rodent malaria Plasmodium chabaudi." Mol Biochem Parasitol 5: 33-44. Newbold, C. I., M. Schryer et al. (1984). "A possible molecular basis for strain specific immunity to malaria." Mol Biochem Parasitol 11: 337-347. Nguer, C. M., A. Diouf et al. (1997). "[Specific antibodies against Plasmodium falciparum antigens in immune subjects: II. Screening of responses against the merozoite major surface antigen (MSP!)]." Dakar Med 42(2): 106-10. Nguer, C. M., T. O. Diallo et al. (1997). "Plasmodium falciparum- and merozoite surface protein 1-specific antibody isotype balance in immune Senegalese adults." Infect. Immun. 65(11): 4873-4876. Noe, A. R. and J. H. Adams (1998). "Plasmodium yoelii YM MAEBL protein is coexpressed and colocalizes with rhoptry proteins." Mol Biochem Parasitol 96(1-2): 27-35. Ntoumi, F., C. Rogier et al. (1997). "Imbalanced distribution of Plasmodium falciparum MSP-1 genotypes related to sickle-cell trait." Mol Med 3(9): 581-92. O'Dea, K. P., P. G. McKean et al. (1995). "Processing of the Plasmodium chabaudi chabaudi AS merozoite surface protein 1 in vivo and in vitro." Mol Biochem Parasitol 72(1-2): 111-9. O'Dea, K. P., P. G. McKean et al. (1996). "A single gene copy merozoite surface antigen and immune evasion?" Parasite Immunol 18(4): 165-72. O'Donnell, R. A., A. Saul et al. (2000). "Functional conservation of the malaria vaccine antigen MSP-119 across distantly related Plasmodium species." Nature Med. 6(1): 91-95. Ockenhouse, C. F., P.-F. Sun et al. (1998). "Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria." J. Infect. Dis. 177: 1664-1673. Odink, K. G., M. J. Lockyer et al. (1984). "Expression of cloned cDNA for a major surface antigen of Plasmodium falciparum merozoites." Febs Lett 173: 108-112. Ohrt, C., L. Mirabelli-Primdahl et al. (1997). "Distinguishing Plasmodium falciparum treatment failures from reinfections by restrictions fragment length polymorphism and polymerase chain reaction genotyping." Am J Trop Med Hyg 57(4): 430-7. Ohta, N., K. Iwaki et al. (1997). "Epitope analysis of human T- cell response to MSP-1 of Plasmodium falciparum in malaria- nonexposed individuals." Int Arch Allergy Immunol 114(1): 15-22. Oka, M., M. Aikawa et al. (1984). "Ultrastructural localization of protective antigens of Plasmodium yoelii merozoites by the use of monoclonal antibodies and ultrathin cryomicrotomy." Am J Trop Med Hyg 33: 342-346. Okoyeh, J. N., C. R. Pillai et al. (1999). "Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin A." Infect. Immunity 67(11): 5784-5791. Olafsson, P., H. Matile et al. (1992). "Plasmodium falciparum: the repetitive MSA-1 surface protein of the RO-71 isolate is recognized by mouse antibody against the nonrepetitive repeat block of RO-33." Exp Parasitol 74(4): 381-9. Pan, W., E. Ravot et al. (1999). "Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells." Nucleic Acids Res 27(4): 1094-103. Pan, W. Q., E. Ravot et al. (1999). "Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells." Nucl. Acids Res. 27(4): 1094-1103. Pasay, M. C., Q. Cheng et al. (1995). "Dimorphism of the C terminus of the Plasmodium vivax merozoite surface protein 1." Molecular & Biochemical Parasitology 70(1-2): 217-9. Patarroyo, M. E., P. Romero et al. (1987). "Induction of protective immunity against experimental infection with malaria using synthetic peptides." Nature 328: 629-632. Patarroyo, M. E., P. Romero et al. (1987). Protective synthetic peptides against experimental Plasmodium falciparum-induced malaria. Vaccines 87. R. A. Lerner. Cold Spring Harbour, Cold Spring Harbour Laboratory: 117-124. Patarroyo, M. E., R. Amador et al. (1988). "A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria." Nature 332: 158-161. Perera, K. L., S. M. Handunnetti et al. (1998). "Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria." Infect Immun 66(4): 1500-6. Perkins, M. (1982). "Surface proteins of schizont-infected erythrocytes and merozoites of Plasmodium falciparum." Mol Biochem Parasitol 5: 55-64. Perkins, M. E. (1984). "Surface proteins of Plasmodium falciparum merozoites binding to the erythrocyte receptor, glycophorin." J Exp Med 160: 788-798. Perkins, M. E. and J. V. Ravetch (1986). Interaction of Plasmodium falciparum merozoite proteins with the erythrocyte surface. Vaccines 86. R. A. Lerner. Cold Spring Harbor, Cold Spring Harbor Laboratory. ?: 157-160. Perkins, M. E. and L. J. Rocco (1988). "Sialic acid-dependent binding of Plasmodium falciparum merozoite surface antigen, Pf200, to human erythrocytes." J Immunol 141: 3190-3196. Perkins, M. E. and L. J. Rocco (1990). "Chemical cross-linking of Plasmodium falciparum glycoprotein, Pf200 (190-205 kDa), to the S- antigen at the merozoite surface." Exp Parasitol 70: 207-216. Perrin, L. H. and R. Dayal (1982). "Immunity to asexual erythrocytic stages of Plasmodium falciparum: role of defined antigens in the humoral response." Immunol Rev 61: 245-269. Perrin, L. H., B. Merkli et al. (1984). "Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages." J Exp Med 160: 441-451. Perrin, L. H., M. Loche et al. (1984). "Immunization against Plasmodium falciparum asexual blood stages using soluble antigens." Clin Exp Immunol 56: 67-72. Perrin, L. H., B. Merkli et al. (1985). "Immunization with a Plasmodium falciparum merozoite surface antigen induces a partial immunity in monkeys." J Clin Invest 75: 1718-1721. Peterson, M. G., R. L. Coppel et al. (1988). "Third form of the precursor to the major merozoite surface antigens of Plasmodium falciparum." Mol Cell Biol 8: 2664-2667. Peterson, M. G., R. L. Coppel et al. (1988). "Variation in the precursor to the major merozoite surface antigens of Plasmodium falciparum." Mol Biochem Parasitol 27: 291-302. Pirson, P. J. and M. E. Perkins (1985). "Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites." J Immunol 134: 1946-1951. Playfair, J. H., S. J. De et al. (1985). "Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity." Clin Exp Immunol 62: 19-23. Porto, M., M. U. Ferreira et al. (1992). "Second form in a segment of the merozoite surface protein 1 gene of Plasmodium vivax among isolates from Rondonia (Brazil)." Mol Biochem Parasitol 54(1): 121-4. Premawansa, S., V. A. Snewin et al. (1993). "Plasmodium-Vivax - Recombination Between Potential Allelic Types of the Merozoite Surface Protein MSP1 in Parasites Isolated from Patients." Exp Parasitol 76: 192-199. Qari, S. H., Y. P. Shi et al. (1998). "Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP- 1), a potential malaria vaccine antigen." Mol Biochem Parasitol 92(2): 241-52. Ramasamy, R. and R. T. Reese (1986). "Terminal galactose residues and the antigenicity of Plasmodium falciparum glycoproteins." Mol Biochem Parasitol 19: 91-101. Ramasamy, R. (1987). "Studies on glycoproteins in the human malaria parasite Plasmodium falciparum--lectin binding properties and the possible carbohydrate-protein linkage." Immunol Cell Biol 65: 147-152. Ramasamy, R., K. Nagendran et al. (1994). "Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka." American Journal of Tropical Medicine & Hygiene 50(5): 537-47. Ramasamy, R., K. Nagendran et al. (1995). "Dynamics of natural antibody responses to malaria parasite surface proteins in the intermediate rainfall zone of Sri Lanka." Indian Journal of Medical Research 101: 66-74. Ramasamy, R., D. A. Wijesundere et al. (1995). "Antibody and clinical responses in volunteers to immunization with malaria peptide-diptheria toxoid conjugates." Clinical & Experimental Immunology 99(2): 168-74. Ramasamy, R., R. Kanagaratnam et al. (1999). "Model multiple antigenic and homopolymeric peptides from non-repetitive sequences of malaria merozoite proteins elicit biologically irrelevant antibodies." Biochim Biophys Acta 1453(1): 115-25. Ramasamy, R., S. G. Yasawardena et al. (1999). "Mammalian cell expression of malaria merozoite surface proteins and experimental DNA and RNA immunisation." Biochim Biophys Acta 1453(1): 1-13. Ranford-Cartwright, L., P. Balfe et al. (1991). "Direct sequencing of enzymatically amplified DNA of alleles of the merozoite surface antigen MSA-1 gene from the malaria parasite Plasmodium falciparum." Mol Biochem Parasitol 46(1): 185-188. Ranford-Cartwright, L. C., P. Balfe et al. (1991). "Genetic hybrids of Plasmodium falciparum identified by amplification of genomic DNA from single oocysts." Mol Biochem Parasitol 49(2): 239-244. Ranford-Cartwright, L. C., P. Balfe et al. (1993). "Frequency of cross-fertilization in the human malaria parasite Plasmodium falciparum." Parasitology 107(Pt 1): 11-8. Ranford-Cartwright, L. C., J. Taylor et al. (1997). "Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon." Trans R Soc Trop Med Hyg 91(6): 719-24. Ranford-Cartwright, L. and D. Walliker (1999). "Intragenic recombinants of Plasmodium falciparum identified by in situ polymerase chain reaction." Mol. Biochem. Parasitol. 102(1): 13- 20. Ranjit, M. R. and Y. D. Sharma (1999). "Genetic polymorphism of falciparum malaria vaccine candidate antigen genes among field isolates in India." Am. J. Trop. Med. Hyg. 61(1): 103-108. Reeder, J. C. and V. M. Marshall (1994). "A simple method for typing Plasmodium falciparum merozoite surface antigens 1 and 2 (MSA-1 and MSA-2) using a dimorphic-form specific polymerase chain reaction." Mol Biochem Parasitol 68: 329-332. Renia, L., I. T. Ling et al. (1997). "Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge." Infect Immun 65(11): 4419-23. Riley, E., S. Bennett et al. (1992). "MHC and malaria: the relationship between HLA class II alleles and immune responses to Plasmodium falciparum." Int. Immunol. 4: 1055-1063. Riley, E. M., S. J. Allen et al. (1992). "Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity." Parasite Immunol 14: 321-337. Riley, E. M., S. Morrisjones et al. (1993). "A Longitudinal Study of Naturally Acquired Cellular and Humoral Immune Responses to a Merozoite Surface Protein (MSP1) of Plasmodium-Falciparum in an Area of Seasonal Malaria Transmission." Parasite Immunol 15: 513- 524. Riley, E. M., S. Morrisjones et al. (1993). "Lymphoproliferative Responses to a Merozoite Surface Antigen of Plasmodium-falciparum - Preliminary Evidence for Seasonal Activation of CD8+/HLA-DQ- Restricted Suppressor Cells." Clin Exp Immunol 94: 64-67. Robert, F., F. Ntoumi et al. (1996). "Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal." Trans R Soc Trop Med Hyg 90(6): 704-11. Rogers, W. O., K. Gowda et al. (1999). "Construction and immunogenicity of DNA vaccine encoding four Plasmodium vivax candidate vaccine plasmids antigens." Vaccine 17(23-24): 3136- 3144. Roper, C., W. Richardson et al. (1998). "Seasonal changes in the Plasmodium falciparum population in individuals and their relationship to clinical malaria: a longitudinal study in a Sudanese village." Parasitology 116(Pt 6): 501-10. Rotman, H. L., T. M. Daly et al. (1998). "Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model." J Immunol 161(4): 1908-12. Rotman, H. L., T. M. Daly et al. (1999). "Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge." Exp Parasitol 91(1): 78-85. Rzepczyk, C. M., R. Ramasamy et al. (1989). "Analysis of human T- cell response to 2 Plasmodium- falciparum merozoite surface antigens." Eur. J. Immunol. 19: 1797-1802. Sakihama, N., M. Kimura et al. (1999). "Allelic recombination and linkage disequilibrium within Msp-1 of Plasmodium falciparum, the malignant human malaria parasite." Gene 230(1): 47-54. Sam-yellowe, T. Y. and R. C. Judd (1990). "Passive immunization against Plasmodium-chabaudi malaria with pch 21 merozoite monoclonal antibody." Parasitol. Res 76: 457-460. Sandhu, J. S. and J. F. Kennedy (1994). "Expression of the Merozoite Surface Protein Gp195 in Vaccinia Virus." Vaccine 12: 56-64. Saul, A., G. Lawrence et al. (1999). "Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant." Vaccine 17(23-24): 3145-3159. Scaife, J., N. Bone et al. (1986). "Antigens of Plasmodium falciparum blood stages with clinical interest cloned and expressed in E. coli." Parasitology. Scherf, A., P. Barbot et al. (1989). "Sequence and length polymorphism of a major malaria vaccine candidate analysed following DNA amplification." Nucleic Acids Res 17: 1774-1774. Scherf, A. and E. Kimura (1990). "The major merozoite surface antigen (MSAI) of Plasmodium falciparum." Parasitol Today 6(12): 391-392. Scherf, A., D. Mattei et al. (1991). "Multiple infections and unusual distribution of block 2 of the MSA1 gene of Plasmodium falciparum detected in West African clinical isolates by polymerase chain reaction analysis." Mol Biochem Parasitol 44(2): 297-300. Schmidt-Ullrich, R., D. F. Wallach et al. (1979). "Two Plasmodium knowlesi-specific antigens on the surface of schizont-infected Rhesus monkey erythrocytes induce antibody production in immune hosts." J Exp Med 150(86): 86-99. Schmidt-Ullrich, R., J. Lightholder et al. (1983). "Protective Plasmodium knowlesi Mr 74,000 antigen in membranes of schizont- infected rhesus erythrocytes." J Exp Med 158: 146. Schmidt-Ullrich, R., J. Brown et al. (1986). "Human-human hybridomas secreting monoclonal antibodies to the Mr 195,000 Plasmodium falciparum blood stage antigen." J Exp Med 163: 179- 188. Schmidt-Ullrich, R., D. F. Wallach et al. (1986). "Membrane orientation and antigenic peptides of an immunoprotective 74 kDa Plasmodium knowlesi glycoprotein." Mol Biochem Parasitol 20: 15- 23. Schwarz, R. T., M. V. Riveros et al. (1986). "Structural diversity of the major surface antigen of Plasmodium falciparum merozoites." Mol Cell Biol 6: 964-968. Seesod, N., J. Lundeberg et al. (1993). "Immunomagnetic Purification to Facilitate DNA Diagnosis of Plasmodium- Falciparum." J Clin Microbiol 31: 2715-2719. Shai, S., M. J. Blackman et al. (1995). "Epitopes in the 19kDa fragment of the Plasmodium falciparum major merozoite surface protein-1 (PfMSP-1(19)) recognized by human antibodies." Parasite Immunol 17(5): 269-75. Shi, Y. P., S. E. Hasnain et al. (1999). "Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine." Proc. Nat. Acad. Sci. USA 96(4): 1615-1620. Siddiqui, W. A., L. Q. Tam et al. (1986). "Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys." Infect Immun 52: 314-318. Siddiqui, W. A., L. Q. Tam et al. (1987). "Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria." Proc Natl Acad Sci U S A 84: 3014- 3018. Simitsek, P. D., E. Ramirez et al. (1990). "Structural diversity of Plasmodium falciparum gp200 is detected by T cells." Eur J Immunol 20(8): 1755-1759. Sinigaglia, F., B. Takacs et al. (1988). "Nonpolymorphic regions of p190, a protein of the Plasmodium falciparum erythrocytic stage, contain both T and B cell epitopes." J Immunol 140(3568): 3568-3572. Sinigaglia, F., M. Guttinger et al. (1990). "Malaria antigens and MHC restriction." Immunol Lett 25(1-3): 265-270. Snewin, V. A., M. Herrera et al. (1991). "Polymorphism of the alleles of the merozoite surface antigens MSA1 and MSA2 in Plasmodium falciparum wild isolates from Colombia." Mol Biochem Parasitol 49(2): 265-276. Snounou, G., X. P. Zhu et al. (1999). "Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand." Trans. Roy. Soc. Trop. Med. Hyg. 93(4): 369-374. Soares, I. S., S. G. Oliveira et al. (1999). "Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil." Acta Trop 72(1): 13-24. Soares, I. S., M. G. da Cunha et al. (1999). "Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein I." Am. J. Trop. Med. Hyg. 60(3): 357-363. Soares, I. S., J. W. Barnwell et al. (1999). "A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies." Mol. Med. 5(7): 459-470. Somner, E. A., S. A. Ogun et al. (1999). "Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains." Microbiology 145(Pt 1): 221-9. Spencer Valero, L. M., S. A. Ogun et al. (1998). "Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia." Infect Immun 66(8): 3925-30. Spetzler, J. C., C. Rao et al. (1994). "A novel strategy for the synthesis of the cysteine-rich protective antigen of the malaria merozoite surface protein (MSP-1). Knowledge- based strategy for disulfide formation." Int J Pept Protein Res 43(4): 351-8. Stafford, W., M. J. Blackman et al. (1994). "N-terminal amino acid sequence of the Plasmodium falciparum merozoite surface protein-1 polypeptides." Mol Biochem Parasitol 66: 157-160. Stanley, H. A. and R. T. Reese (1985). "Monkey-derived monoclonal antibodies against Plasmodium falciparum." Proc Natl Acad Sci U S A 82: 6272-6275. Stirnadel, H. A. (1999). The relative contribution of genetic and environmental factors to variation in malaria immunity, infection and related morbidity, in areas highly endemic for Plasmodium falciparum, University of Basel, Switzerland. Strych, W., B. A. Miettinen et al. (1987). "Isolation and characterization of the 80,000 dalton Plasmodium falciparum merozoite surface antigen." Parasitol Res 73(435): 435-441. Su, S. D., A. R. Sanadi et al. (1993). "A Monoclonal Antibody Capable of Blocking the Binding of PF200 (MSA-1) to Human Erythrocytes and Inhibiting the Invasion of Plasmodium-Falciparum Merozoites into Human Erythrocytes." J Immunol 151: 2309-2317. Suhrbier, A., A. A. Holder et al. (1989). "Expression of the precursor of the major merozoite surface antigens during the hepatic stage of malaria." Am J Trop Med Hyg 40(351): 351-355. Suss, G. and J. R. Pink (1992). "A recombinant malaria protein that can induce Th1 and CD8+ T cell responses without antibody formation." J Immunol 149(4): 1334-9. Suss, G., H. Matile et al. (1993). "Identifying Polymorphic Regions of the p190 Protein from Different Plasmodium-Falciparum Strains by Using Specific T-Cells." Parasite Immunol 15: 127-134. Szarfman, A., D. Walliker et al. (1988). "Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages." J Exp Med 167: 231-236. Szarfman, A., J. A. Lyon et al. (1988). "Mature liver stages of cloned Plasmodium falciparum share epitopes with proteins from sporozoites and asexual blood stages." Parasite Immunol 10: 339- 351. Tanabe, K., M. Mackay et al. (1987). "Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum." J Mol Biol 195: 273-287. Tanabe, K., K. Murakami et al. (1989). "Plasmodium falciparum: dimorphism of the p190 alleles." Exp Parasitol 68(470): 470-473. Tanabe, K., N. Sakihama et al. (2000). "Selection and genetic drift of polymorphisms within the merozoite surface protein-1 gene of Plasmodium falciparum." Gene 241(2): 325-331. Taylor, R. R., A. Egan et al. (1996). "Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting." Int Immunol 8(6): 905-15. Terrientes, Z. I., K. Kramer et al. (1994). "Naturally acquired antibodies against the major merozoite surface coat protein (MSP- 1) of Plasmodium falciparum acquired by residents in an endemic area of Colombia." Mem Inst Oswaldo Cruz 89(Suppl 2): 55-61. Tian, J. H., L. H. Miller et al. (1996). "Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine." J Immunol 157(3): 1176-83. Tian, J. H., S. Kumar et al. (1997). "Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii." Infect Immun 65(8): 3032-6. Tian, J. H., M. F. Good et al. (1998). "Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria." Parasite Immunol 20(6): 263-78. Tolle, R., K. Fruh et al. (1993). "A Prospective Study of the Association Between the Human Humoral Immune Response to Plasmodium-Falciparum Blood Stage Antigen-gp190 and Control of Malarial Infections." Infect Immun 61: 40-47. Tolle, R., H. Bujard et al. (1995). "Plasmodium falciparum: variations within the C-terminal region of merozoite surface antigen-1." Experimental Parasitology 81(1): 47-54. Udagama, P. V., A. C. Gamagemendis et al. (1990). "Genetic complexity of plasmodium-vivax parasites in individual human infections analyzed with monoclonal antibodies against variant epitopes on a single parasite protein." Am. J. Trop. Med Hyg 42: 104-110. Udhayakumar, V., D. Anyona et al. (1995). "Identification of T and B cell epitopes recognized by humans in the C- terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1." J Immunol 154(11): 6022-30. Urquiza, M., L. E. Rodriguez et al. (1996). "Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells." Parasite Immunol 18(10): 515-26. Vaidya, A. B., W. A. Schleif et al. (1984). "Analysis of mRNA coding for blood-stage antigens of a rodent malarial parasite, Plasmodium yoelii: mRNA coding for a possible protective antigen purify as poly A-." J Immunol 132: 3126-3130. Viriyakosol, S., N. Siripoon et al. (1995). "Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies." Bull World Health Organ 73(1): 85-95. Von Brunn, A., K. Früh et al. (1991). "Epitopes of the human malaria parasite P. falciparum carried on the surface of HBsAg particles elicit an immune response against the parasite." Vaccine 9(7): 477-484. Weber, J. L., W. M. Leininger et al. (1986). "Variation in the gene encoding a major merozoite surface antigen of the human malaria parasite Plasmodium falciparum." Nucleic Acids Res 14: 3311-3323. Weber, J. L., J. A. Lyson et al. (1987). Blood stage antigen genes of Plasmodium falciparum. New York, Alan R Liss Inc. Weber, J. L., B. K. Sim et al. (1988). "Merozoite surface protein sequence from the Camp strain of the human malaria parasite Plasmodium falciparum." Nucleic Acids Res 16(1206): 1206-1206. Wilson, C. F., R. Anand et al. (1987). "Topography of epitopes on a polymorphic schizont antigen of Plasmodium falciparum determined by the binding of monoclonal antibodies in a two-site radioimmunoassay." Parasite Immunol 9(737): 737-746. Wiser, M. F. (1986). "Characterization of monoclonal antibodies directed against erythrocytic stage antigens of Plasmodium berghei." Eur J Cell Biol 42: 45-51. Wiser, M. F. and H. G. Schweiger (1986). "Increased sensitivity in antigen detection during immunoblot analysis resulting from antigen enrichment via immunoprecipitation." Anal Biochem 155(71): 71-77. Wood, J. C., J. C. S. Deaguiar et al. (1989). "In vivo selection of populations of Plasmodium chabaudi chabaudi that are resistant to a monoclonal antibody that reacts with the precursor to the major merozoite surface antigen." Infect. Immun 57: 2128-2135. Wu, L. J., E. X. Liu et al. (1993). "[Ultrastructural localization of 185 kDa and 82/41 kDa protective antigens in Plasmodium falciparum, FCC1/HN]. [Chinese]." Chung Kuo Chi Sheng Chung Hsueh Yu Chi Sheng Chung Ping Tsa Chih Chinese Journal of Parasitology & Parasitic Diseases 11(1): 25-8. Yang, C., W. E. Collins et al. (1996). "Influence of adjuvants on murine immune responses against the C- terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein- 1 (MSP-1)." Parasite Immunol 18(11): 547-58. Yang, C., W. E. Collins et al. (1999). "Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant." Infect Immun 67(1): 342-9. Yang, S. T., D. Nikodem et al. (1999). "Glycosylation and proteolytic processing of 70 kDa C-terminal recombinant polypeptides of Plasmodium falciparum merozoite surface protein 1 expressed in mammalian cells." Glycobiology 9(12): 1347-1356. Zhong, H. B., J.-Y. Fan et al. (1999). "Cloning and characterization of the merozoite surface antigen 1 gene of Plasmodium berghei." Am. J. Trop. Med. Hyg. 60(6): 994-999. Zwetyenga, J., C. Rogier et al. (1998). "No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria." Am J Trop Med Hyg 59(5): 726-35. Zwetyenga, J., C. Rogier et al. (1999). "A cohort study of Plasmodium falciparum diversity during the dry season in Ndiop, a Senegalese village with seasonal, mesoendemic malaria." Trans. Roy. Soc. Trop. Med. Hyg. 93(4): 375-380.